Skip to main navigation Skip to search Skip to main content

FDA approval Aducanumab

Press/Media: exportcomment

Period7 Jun 2021

Media contributions

1

Media contributions

  • TitleOp1
    Media name/outletNPO1
    Country/TerritoryNetherlands
    Date07/06/2021
    PersonsPhilip Scheltens
View all 1
View less